NCT05827042View on ClinicalTrials.gov

Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

PHASE3RecruitingINTERVENTIONAL
Enrollment

338

Participants

Timeline

Start Date

May 9, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Basilar Artery OcclusionAcute Cerebrovascular AccidentStroke Due to Basilar Artery Occlusion
Interventions
DRUG

Intravenous thrombolysis

Patients will receive intravenous alteplase (0.9mg/kg, maximum 90mg) or tenecteplase (0.25mg/kg, maximum 25mg) before endovascular thrombectomy.

PROCEDURE

Endovascular thrombectomy

Endovascular thrombectomy

Trial Locations (1)

230001

RECRUITING

The First Affiliated Hospital of University of Science and Technology of China, Hefei

All Listed Sponsors
lead

The First Affiliated Hospital of University of Science and Technology of China

OTHER